• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

United Therapeutics Corp

+ Add to Watchlist

UTHR:US

90.9400 USD 2.3500 2.52%

As of 20:10:00 ET on 07/31/2014.

Snapshot for United Therapeutics Corp (UTHR)

Open: 92.7200 Day's Range: 89.3600 - 93.2400 Volume: 733,808
Previous Close: 93.2900 52wk Range: 70.3400 - 116.6500 1-Yr Rtn: +19.86%

Stock Chart for UTHR

No chart data available.
  • UTHR:US 90.9400
  • 1D
  • 1M
  • 1Y
93.2900
Interactive UTHR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UTHR

Current P/E Ratio (ttm) 17.8314
Estimated P/E(12/2014) 9.7596
Relative P/E vs. SPX 1.0145
Earnings Per Share (USD) (ttm) 5.1000
Est. EPS (USD) (12/2014) 9.3180
Est. PEG Ratio 0.9760
Market Cap (M USD) 4,298.68
Shares Outstanding (M) 47.27
30 Day Average Volume 686,930
Price/Book (mrq) 3.5407
Price/Sale (ttm) 3.7406
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UTHR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for UTHR

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

Martine A RothblattChairman/CEO/FounderRoger A JeffsPresident/COO
John M FerrariCFO/TreasurerShola OyewoleChief Information Officer
More Company Profile & Key Executives for UTHR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil